List of works - Jon P Gockerman

"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma

scientific article

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma ⬇️

scientific article published on February 13, 2013

Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia

scientific article published on May 2002

Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma

scientific article published on 01 June 2004

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas

scientific article

Non-Hodgkin's Lymphomas, version 3.2012

scientific article published on 01 December 2012

Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology

scientific article published on 01 March 2006

Non-Hodgkin's lymphomas

scientific article published on 01 April 2008

Non-Hodgkin's lymphomas

scientific article published on 01 May 2011

Non-Hodgkin's lymphomas, version 1.2013.

scientific article

Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia

scientific article published on 01 July 2009

Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy

scientific article published in July 2010

Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution

scientific article

Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma

scientific article published on 20 April 2004

Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia

scientific article

Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival

scientific article

List of works by Jon P Gockerman

"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma ⬇️

Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia

Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas

Non-Hodgkin's Lymphomas, version 3.2012

Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology

Non-Hodgkin's lymphomas

Non-Hodgkin's lymphomas

Non-Hodgkin's lymphomas, version 1.2013.

Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia

Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy

Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution

Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma

Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia

Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival